The oral progestational and anti-ovulatory properties of megestrol acetate and its therapeutic use in gynaecological disorders.
D000568:Amenorrhea; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004194:Disease; D004412:Dysmenorrhea; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006470:Hemorrhage; D019290:Megestrol Acetate; D008599:Menstruation Disturbances; D008656:Mestranol; D008796:Metrorrhagia; D012106:Research; D012816:Signs and Symptoms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D008656:Mestranol; D019290:Megestrol Acetate
Amenorrhea; Bleeding; Clinical Research; Contraception; Contraceptive Agents, Estrogen--therapeutic use; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Contraceptive Effectiveness; Diseases; Dysmenorrhea; Family Planning; Megestrol Acetate--therapeutic use; Menstruation Disorders; Mestranol--therapeutic use; Metrorrhagia; Research Methodology; Signs And Symptoms; Use-effectiveness